Kuroda S - Search Results

1

Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: An open-label, phase 3 exploratory study.

Inagaki N, Sano H, Seki Y, Kuroda S, Kaku K. Inagaki N, et al. Among authors: kuroda s. J Diabetes Investig. 2018 Mar;9(2):354-359. doi: 10.1111/jdi.12730. Epub 2017 Oct 30. J Diabetes Investig. 2018. PMID: 28836351 Free PMC article. Clinical Trial.

2

SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.

Inagaki N, Onouchi H, Sano H, Funao N, Kuroda S, Kaku K. Inagaki N, et al. Among authors: kuroda s. Lancet Diabetes Endocrinol. 2014 Feb;2(2):125-32. doi: 10.1016/S2213-8587(13)70149-9. Epub 2013 Nov 1. Lancet Diabetes Endocrinol. 2014. PMID: 24622716 Clinical Trial.

3

Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study.

Inagaki N, Onouchi H, Maezawa H, Kuroda S, Kaku K. Inagaki N, et al. Among authors: kuroda s. Lancet Diabetes Endocrinol. 2015 Mar;3(3):191-7. doi: 10.1016/S2213-8587(14)70251-7. Epub 2015 Jan 19. Lancet Diabetes Endocrinol. 2015. PMID: 25609193 Clinical Trial.

4

Long-term safety and efficacy of a novel once-weekly oral trelagliptin as monotherapy or in combination with an existing oral antidiabetic drug in patients with type 2 diabetes mellitus: A 52-week open-label, phase 3 study.

Inagaki N, Sano H, Seki Y, Kuroda S, Kaku K. Inagaki N, et al. Among authors: kuroda s. J Diabetes Investig. 2016 Sep;7(5):718-26. doi: 10.1111/jdi.12499. Epub 2016 Mar 28. J Diabetes Investig. 2016. PMID: 27181699 Free PMC article. Clinical Trial.

5

Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study.

Kaku K, Kuroda S, Ishida K, Umeda Y. Kaku K, et al. Among authors: kuroda s. Diabetes Obes Metab. 2018 Oct;20(10):2490-2493. doi: 10.1111/dom.13397. Epub 2018 Jul 2. Diabetes Obes Metab. 2018. PMID: 29862617 Free PMC article. Clinical Trial.

6

Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria: A Randomized, Controlled Trial.

Ito S, Kagawa T, Saiki T, Shimizu K, Kuroda S, Sano Y, Umeda Y. Ito S, et al. Among authors: kuroda s. Clin J Am Soc Nephrol. 2019 Mar 7;14(3):354-363. doi: 10.2215/CJN.07720618. Epub 2019 Feb 12. Clin J Am Soc Nephrol. 2019. PMID: 30755452 Free PMC article. Clinical Trial.

7

Pharmacokinetics, Pharmacodynamics and Safety of a Single Dose of Imarikiren, a Novel Renin Inhibitor, in Healthy Male Subjects.

Matsuno K, Kuroda S, Tanaka S, Nakamichi H, Kagawa T, Koumura E. Matsuno K, et al. Among authors: kuroda s. Basic Clin Pharmacol Toxicol. 2018 Nov;123(5):607-614. doi: 10.1111/bcpt.13050. Epub 2018 Jul 12. Basic Clin Pharmacol Toxicol. 2018. PMID: 29845723 Free article. Clinical Trial.

8

Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic Impairment.

Shimasaki Y, Sakaki M, Itou M, Kobayashi T, Aso M, Kagawa T, Saiki T, Matsuno K, Sano Y, Shimizu K, Kuroda S, Koumura E. Shimasaki Y, et al. Among authors: kuroda s. Clin Drug Investig. 2018 Nov;38(11):1041-1051. doi: 10.1007/s40261-018-0695-4. Clin Drug Investig. 2018. PMID: 30194585 Clinical Trial.

9

Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.

Tomita Y, Tatsugami K, Nakaigawa N, Osawa T, Oya M, Kanayama H, Nakayama Kondoh C, Sassa N, Nishimura K, Nozawa M, Masumori N, Miyoshi Y, Kuroda S, Tanaka S, Kimura A, Tamada S. Tomita Y, et al. Among authors: kuroda s. Int J Urol. 2020 Nov;27(11):952-959. doi: 10.1111/iju.14329. Epub 2020 Aug 12. Int J Urol. 2020. PMID: 32789967 Free PMC article. Clinical Trial.

10

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study.

Kudo M, Tsuchiya K, Kato N, Hagihara A, Numata K, Aikata H, Inaba Y, Kondo S, Motomura K, Furuse J, Ikeda M, Morimoto M, Achira M, Kuroda S, Kimura A. Kudo M, et al. Among authors: kuroda s. J Gastroenterol. 2021 Feb;56(2):181-190. doi: 10.1007/s00535-020-01753-0. Epub 2021 Jan 3. J Gastroenterol. 2021. PMID: 33392749 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,956 results

Search Page